APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acute Sinusitis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acute Sinusitis Market Analysis and Forecast 2026-2032

19 December 2025204 pages

Choose your research edition.

Industry ResearchAcute Sinusitis Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Sinusitis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Acute Sinusitis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Sinusitis Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Sinusitis Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Acute Sinusitis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Acute Sinusitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acute Sinusitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acute Sinusitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acute Sinusitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Acute Sinusitis include Bionorica, Bristol-Myers Squibb, Dr. Reddy's Laboratories, AstraZeneca, Amgen, Bayer, Fresenius Kabi, Pfizer and Eli Lilly and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Acute Sinusitis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acute Sinusitis, also provides the revenue of main regions and countries. Of the upcoming market potential for Acute Sinusitis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acute Sinusitis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acute Sinusitis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Acute Sinusitis revenue, projected growth trends, production technology, application and end-user industry.

Acute Sinusitis Segment by Company

Bionorica

Bristol-Myers Squibb

Dr. Reddy's Laboratories

AstraZeneca

Amgen

Bayer

Fresenius Kabi

Pfizer

Eli Lilly and Company

Merck

Novartis

Johnson & Johnson

Sanofi

Sun Pharmaceutical

Teva Pharmaceutical

Abbott

Acute Sinusitis Segment by Type

Saline Nasal Spray

Nasal Corticosteroids

OTC Pain Relievers

Others

Acute Sinusitis Segment by Application

Hospital

Clinic

Acute Sinusitis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Sinusitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Sinusitis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Sinusitis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Acute Sinusitis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Acute Sinusitis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Sinusitis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acute Sinusitis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Saline Nasal Spray Major Player Table 3. Nasal Corticosteroids Major Player Table 4. OTC Pain Relievers Major Player Table 5. Others Major Player Table 6. Global Acute Sinusitis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Acute Sinusitis Industry Trends Table 10. Acute Sinusitis Industry Drivers Table 11. Acute Sinusitis Industry Opportunities and Challenges Table 12. Acute Sinusitis Industry Restraints Table 13. Global Acute Sinusitis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Acute Sinusitis Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Acute Sinusitis Market Share by Region (2021-2026) Table 16. Global Acute Sinusitis Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Acute Sinusitis Market Share by Region (2027-2032) Table 18. Global Acute Sinusitis Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Acute Sinusitis Revenue Market Share by Players (2021-2026) Table 20. Global Acute Sinusitis Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Acute Sinusitis Key Players Headquarters & Area Served Table 22. Global Acute Sinusitis Players, Product Type & Application Table 23. Global Acute Sinusitis Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Acute Sinusitis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Acute Sinusitis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Acute Sinusitis Revenue Market Share by Type (2021-2026) Table 30. Global Acute Sinusitis Revenue Market Share by Type (2027-2032) Table 31. Global Acute Sinusitis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Acute Sinusitis Revenue Market Share by Application (2021-2026) Table 35. Global Acute Sinusitis Revenue Market Share by Application (2027-2032) Table 36. Bionorica Company Information Table 37. Bionorica Business Overview Table 38. Bionorica Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bionorica Acute Sinusitis Product Portfolio Table 40. Bionorica Recent Development Table 41. Bristol-Myers Squibb Company Information Table 42. Bristol-Myers Squibb Business Overview Table 43. Bristol-Myers Squibb Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bristol-Myers Squibb Acute Sinusitis Product Portfolio Table 45. Bristol-Myers Squibb Recent Development Table 46. Dr. Reddy's Laboratories Company Information Table 47. Dr. Reddy's Laboratories Business Overview Table 48. Dr. Reddy's Laboratories Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Dr. Reddy's Laboratories Acute Sinusitis Product Portfolio Table 50. Dr. Reddy's Laboratories Recent Development Table 51. AstraZeneca Company Information Table 52. AstraZeneca Business Overview Table 53. AstraZeneca Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AstraZeneca Acute Sinusitis Product Portfolio Table 55. AstraZeneca Recent Development Table 56. Amgen Company Information Table 57. Amgen Business Overview Table 58. Amgen Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Amgen Acute Sinusitis Product Portfolio Table 60. Amgen Recent Development Table 61. Bayer Company Information Table 62. Bayer Business Overview Table 63. Bayer Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bayer Acute Sinusitis Product Portfolio Table 65. Bayer Recent Development Table 66. Fresenius Kabi Company Information Table 67. Fresenius Kabi Business Overview Table 68. Fresenius Kabi Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Fresenius Kabi Acute Sinusitis Product Portfolio Table 70. Fresenius Kabi Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Pfizer Acute Sinusitis Product Portfolio Table 75. Pfizer Recent Development Table 76. Eli Lilly and Company Company Information Table 77. Eli Lilly and Company Business Overview Table 78. Eli Lilly and Company Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Eli Lilly and Company Acute Sinusitis Product Portfolio Table 80. Eli Lilly and Company Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Acute Sinusitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Merck Acute Sinusitis Product Portfolio Table 85. Merck Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis Acute Sinusitis Product Portfolio Table 90. Novartis Recent Development Table 91. Johnson & Johnson Company Information Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Johnson & Johnson Acute Sinusitis Product Portfolio Table 95. Johnson & Johnson Recent Development Table 96. Sanofi Company Information Table 97. Sanofi Business Overview Table 98. Sanofi Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi Acute Sinusitis Product Portfolio Table 100. Sanofi Recent Development Table 101. Sun Pharmaceutical Company Information Table 102. Sun Pharmaceutical Business Overview Table 103. Sun Pharmaceutical Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sun Pharmaceutical Acute Sinusitis Product Portfolio Table 105. Sun Pharmaceutical Recent Development Table 106. Teva Pharmaceutical Company Information Table 107. Teva Pharmaceutical Business Overview Table 108. Teva Pharmaceutical Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Teva Pharmaceutical Acute Sinusitis Product Portfolio Table 110. Teva Pharmaceutical Recent Development Table 111. Abbott Company Information Table 112. Abbott Business Overview Table 113. Abbott Acute Sinusitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Abbott Acute Sinusitis Product Portfolio Table 115. Abbott Recent Development Table 116. North America Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Acute Sinusitis Revenue by Country (2021-2026) & (US$ Million) Table 122. North America Acute Sinusitis Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Acute Sinusitis Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe Acute Sinusitis Revenue by Country (US$ Million) & (2027-2032) Table 130. China Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 131. China Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 132. China Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 133. China Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Acute Sinusitis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Acute Sinusitis Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia Acute Sinusitis Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA Acute Sinusitis Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA Acute Sinusitis Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA Acute Sinusitis Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA Acute Sinusitis Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA Acute Sinusitis Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA Acute Sinusitis Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Acute Sinusitis Image Figure 2. Global Acute Sinusitis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acute Sinusitis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Saline Nasal Spray Image Figure 5. Nasal Corticosteroids Image Figure 6. OTC Pain Relievers Image Figure 7. Others Image Figure 8. Global Acute Sinusitis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Acute Sinusitis Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Acute Sinusitis Market Size (US$ Million) & (2021-2032) Figure 13. Global Acute Sinusitis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Acute Sinusitis Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Acute Sinusitis Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Acute Sinusitis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Acute Sinusitis Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Acute Sinusitis Revenue Market Share by Type (2021-2032) Figure 20. Global Acute Sinusitis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Acute Sinusitis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Acute Sinusitis Revenue Market Share by Application (2021-2032) Figure 23. North America Acute Sinusitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Acute Sinusitis Revenue Share by Type (2021-2032) Figure 25. North America Acute Sinusitis Revenue Share by Application (2021-2032) Figure 26. North America Acute Sinusitis Revenue Share by Country (2021-2032) Figure 27. United States Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Acute Sinusitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Acute Sinusitis Revenue Share by Type (2021-2032) Figure 32. Europe Acute Sinusitis Revenue Share by Application (2021-2032) Figure 33. Europe Acute Sinusitis Revenue Share by Country (2021-2032) Figure 34. Germany Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Acute Sinusitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Acute Sinusitis Revenue Share by Type (2021-2032) Figure 44. China Acute Sinusitis Revenue Share by Application (2021-2032) Figure 45. Asia Acute Sinusitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Acute Sinusitis Revenue Share by Type (2021-2032) Figure 47. Asia Acute Sinusitis Revenue Share by Application (2021-2032) Figure 48. Asia Acute Sinusitis Revenue Share by Region (2021-2032) Figure 49. Japan Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Acute Sinusitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Acute Sinusitis Revenue Share by Type (2021-2032) Figure 57. SAMEA Acute Sinusitis Revenue Share by Application (2021-2032) Figure 58. SAMEA Acute Sinusitis Revenue Share by Country (2021-2032) Figure 59. Brazil Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Acute Sinusitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Saline Nasal Spray
  • Nasal Corticosteroids
  • OTC Pain Relievers
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Bionorica
  • Bristol-Myers Squibb
  • Dr. Reddy's Laboratories
  • AstraZeneca
  • Amgen
  • Bayer
  • Fresenius Kabi
  • Pfizer
  • Eli Lilly and Company
  • Merck
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Sun Pharmaceutical
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acute Sinusitis Market by Type
  3. 1.2.1 Global Acute Sinusitis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Saline Nasal Spray
  5. 1.2.3 Nasal Corticosteroids
  6. 1.2.4 OTC Pain Relievers
  7. 1.2.5 Others
  8. 1.3 Acute Sinusitis Market by Application
  9. 1.3.1 Global Acute Sinusitis Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Acute Sinusitis Market Dynamics
  1. 2.1 Acute Sinusitis Industry Trends
  2. 2.2 Acute Sinusitis Industry Drivers
  3. 2.3 Acute Sinusitis Industry Opportunities and Challenges
  4. 2.4 Acute Sinusitis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Acute Sinusitis Market Perspective (2021-2032)
  2. 3.2 Global Acute Sinusitis Growth Trends by Region
  3. 3.2.1 Global Acute Sinusitis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acute Sinusitis Market Size by Region (2021-2026)
  5. 3.2.3 Global Acute Sinusitis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Acute Sinusitis Revenue by Players
  2. 4.1.1 Global Acute Sinusitis Revenue by Players (2021-2026)
  3. 4.1.2 Global Acute Sinusitis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Acute Sinusitis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acute Sinusitis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Acute Sinusitis Key Players Headquarters & Area Served
  7. 4.4 Global Acute Sinusitis Players, Product Type & Application
  8. 4.5 Global Acute Sinusitis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Acute Sinusitis Market CR5 and HHI
  11. 4.6.3 2025 Acute Sinusitis Tier 1, Tier 2, and Tier 3
5 Acute Sinusitis Market Size by Type
  1. 5.1 Global Acute Sinusitis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Acute Sinusitis Revenue by Type (2021-2032)
  3. 5.3 Global Acute Sinusitis Revenue Market Share by Type (2021-2032)
6 Acute Sinusitis Market Size by Application
  1. 6.1 Global Acute Sinusitis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Acute Sinusitis Revenue by Application (2021-2032)
  3. 6.3 Global Acute Sinusitis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bionorica
  2. 7.1.1 Bionorica Company Information
  3. 7.1.2 Bionorica Business Overview
  4. 7.1.3 Bionorica Acute Sinusitis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bionorica Acute Sinusitis Product Portfolio
  6. 7.1.5 Bionorica Recent Developments
  7. 7.2 Bristol-Myers Squibb
  8. 7.2.1 Bristol-Myers Squibb Company Information
  9. 7.2.2 Bristol-Myers Squibb Business Overview
  10. 7.2.3 Bristol-Myers Squibb Acute Sinusitis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bristol-Myers Squibb Acute Sinusitis Product Portfolio
  12. 7.2.5 Bristol-Myers Squibb Recent Developments
  13. 7.3 Dr. Reddy's Laboratories
  14. 7.3.1 Dr. Reddy's Laboratories Company Information
  15. 7.3.2 Dr. Reddy's Laboratories Business Overview
  16. 7.3.3 Dr. Reddy's Laboratories Acute Sinusitis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dr. Reddy's Laboratories Acute Sinusitis Product Portfolio
  18. 7.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Acute Sinusitis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Acute Sinusitis Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Amgen
  26. 7.5.1 Amgen Company Information
  27. 7.5.2 Amgen Business Overview
  28. 7.5.3 Amgen Acute Sinusitis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Amgen Acute Sinusitis Product Portfolio
  30. 7.5.5 Amgen Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Acute Sinusitis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Acute Sinusitis Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Fresenius Kabi
  38. 7.7.1 Fresenius Kabi Company Information
  39. 7.7.2 Fresenius Kabi Business Overview
  40. 7.7.3 Fresenius Kabi Acute Sinusitis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Fresenius Kabi Acute Sinusitis Product Portfolio
  42. 7.7.5 Fresenius Kabi Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Acute Sinusitis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Acute Sinusitis Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Eli Lilly and Company
  50. 7.9.1 Eli Lilly and Company Company Information
  51. 7.9.2 Eli Lilly and Company Business Overview
  52. 7.9.3 Eli Lilly and Company Acute Sinusitis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Eli Lilly and Company Acute Sinusitis Product Portfolio
  54. 7.9.5 Eli Lilly and Company Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck Acute Sinusitis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Merck Acute Sinusitis Product Portfolio
  60. 7.10.5 Merck Recent Developments
  61. 7.11 Novartis
  62. 7.11.1 Novartis Company Information
  63. 7.11.2 Novartis Business Overview
  64. 7.11.3 Novartis Acute Sinusitis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Novartis Acute Sinusitis Product Portfolio
  66. 7.11.5 Novartis Recent Developments
  67. 7.12 Johnson & Johnson
  68. 7.12.1 Johnson & Johnson Company Information
  69. 7.12.2 Johnson & Johnson Business Overview
  70. 7.12.3 Johnson & Johnson Acute Sinusitis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Johnson & Johnson Acute Sinusitis Product Portfolio
  72. 7.12.5 Johnson & Johnson Recent Developments
  73. 7.13 Sanofi
  74. 7.13.1 Sanofi Company Information
  75. 7.13.2 Sanofi Business Overview
  76. 7.13.3 Sanofi Acute Sinusitis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sanofi Acute Sinusitis Product Portfolio
  78. 7.13.5 Sanofi Recent Developments
  79. 7.14 Sun Pharmaceutical
  80. 7.14.1 Sun Pharmaceutical Company Information
  81. 7.14.2 Sun Pharmaceutical Business Overview
  82. 7.14.3 Sun Pharmaceutical Acute Sinusitis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sun Pharmaceutical Acute Sinusitis Product Portfolio
  84. 7.14.5 Sun Pharmaceutical Recent Developments
  85. 7.15 Teva Pharmaceutical
  86. 7.15.1 Teva Pharmaceutical Company Information
  87. 7.15.2 Teva Pharmaceutical Business Overview
  88. 7.15.3 Teva Pharmaceutical Acute Sinusitis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Teva Pharmaceutical Acute Sinusitis Product Portfolio
  90. 7.15.5 Teva Pharmaceutical Recent Developments
  91. 7.16 Abbott
  92. 7.16.1 Abbott Company Information
  93. 7.16.2 Abbott Business Overview
  94. 7.16.3 Abbott Acute Sinusitis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Abbott Acute Sinusitis Product Portfolio
  96. 7.16.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Acute Sinusitis Revenue (2021-2032)
  2. 8.2 North America Acute Sinusitis Revenue by Type (2021-2032)
  3. 8.2.1 North America Acute Sinusitis Revenue by Type (2021-2026)
  4. 8.2.2 North America Acute Sinusitis Revenue by Type (2027-2032)
  5. 8.3 North America Acute Sinusitis Revenue Share by Type (2021-2032)
  6. 8.4 North America Acute Sinusitis Revenue by Application (2021-2032)
  7. 8.4.1 North America Acute Sinusitis Revenue by Application (2021-2026)
  8. 8.4.2 North America Acute Sinusitis Revenue by Application (2027-2032)
  9. 8.5 North America Acute Sinusitis Revenue Share by Application (2021-2032)
  10. 8.6 North America Acute Sinusitis Revenue by Country
  11. 8.6.1 North America Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Acute Sinusitis Revenue by Country (2021-2026)
  13. 8.6.3 North America Acute Sinusitis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Acute Sinusitis Revenue (2021-2032)
  2. 9.2 Europe Acute Sinusitis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Acute Sinusitis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Acute Sinusitis Revenue by Type (2027-2032)
  5. 9.3 Europe Acute Sinusitis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Acute Sinusitis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Acute Sinusitis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Acute Sinusitis Revenue by Application (2027-2032)
  9. 9.5 Europe Acute Sinusitis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Acute Sinusitis Revenue by Country
  11. 9.6.1 Europe Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Acute Sinusitis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Acute Sinusitis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Acute Sinusitis Revenue (2021-2032)
  2. 10.2 China Acute Sinusitis Revenue by Type (2021-2032)
  3. 10.2.1 China Acute Sinusitis Revenue by Type (2021-2026)
  4. 10.2.2 China Acute Sinusitis Revenue by Type (2027-2032)
  5. 10.3 China Acute Sinusitis Revenue Share by Type (2021-2032)
  6. 10.4 China Acute Sinusitis Revenue by Application (2021-2032)
  7. 10.4.1 China Acute Sinusitis Revenue by Application (2021-2026)
  8. 10.4.2 China Acute Sinusitis Revenue by Application (2027-2032)
  9. 10.5 China Acute Sinusitis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acute Sinusitis Revenue (2021-2032)
  2. 11.2 Asia Acute Sinusitis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Acute Sinusitis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Acute Sinusitis Revenue by Type (2027-2032)
  5. 11.3 Asia Acute Sinusitis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Acute Sinusitis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Acute Sinusitis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Acute Sinusitis Revenue by Application (2027-2032)
  9. 11.5 Asia Acute Sinusitis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Acute Sinusitis Revenue by Country
  11. 11.6.1 Asia Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Acute Sinusitis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Acute Sinusitis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acute Sinusitis Revenue (2021-2032)
  2. 12.2 SAMEA Acute Sinusitis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Acute Sinusitis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Acute Sinusitis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Acute Sinusitis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Acute Sinusitis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Acute Sinusitis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Acute Sinusitis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Acute Sinusitis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Acute Sinusitis Revenue by Country
  11. 12.6.1 SAMEA Acute Sinusitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Acute Sinusitis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Acute Sinusitis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst